Dr. Paul Auwaerter discusses therapeutics, vaccines, and more about emerging variants of COVID-19. Topics: * Changes to NIH recommendations for mild to moderate COVID-19 * New monoclonal antibody: bebtelovimab * Monoclonal antibody evasion in omicron sublineages * Revisions to booster dose schedules for immunocompromised people
Faculty
Clinical Director, Division of Infectious Diseases
Sherrilyn and Ken Fisher Professor of Medicine
Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine